Warren Fiskus - Publications, H-index & Citations

Warren Fiskus

University of Texas MD Anderson Cancer Center

56H指数

357论文数

9.2K被引数

收录论文 89

发表时间

High MECOM protein levels confer adverse prognosis in acute myeloid leukemia independent of Chromosome 3 abnormalities 高MECOM蛋白水平在独立于染色体3异常的情况下预示急性髓系白血病的不良预后

Blood Cancer Journal

IF11.6

2026-09-30

OAAI

Steven M. Kornblau; Eduardo Sabino de Camargo Magalhães; Brandon D. Brown; Samanta Soledad Catueno; Yihua Qiu; Eitan Kugler; Abhishek Maiti; Warren C. Fiskus; Tapan Kadia

Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML 更正：基于BET抑制剂的组合，靶向MECOM重排(r) AML中的新型依赖性

Leukemia

IF13.4

2026-03-11

OAAI

Christine E. Birdwell; Warren Fiskus; Christopher P. Mill; Tapan M. Kadia; Naval Daver; Courtney D. DiNardo; Koji Sasaki; John A. Davis; Kaberi Das; Hanxi Hou; Antrix Jain; Anna Malovannaya; Lauren B. Flores; Rasoul Pourebrahim; Selina Yuan; Xiaoping Su; Michele Ceribelli; Kapil N. Bhalla

Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor 通过包含BET蛋白和双重BRG1/BRM抑制剂的组合克服AML细胞中的Menin抑制剂耐药性

Blood

IF23.1

2026-02-26

PREAI

Warren Fiskus; Christopher P. Mill; Ghayas C. Issa; Jessica Piel; Mike Collins; Murphy Hentemann; Branko Cuglievan; Hanxi Hou; Antrix Jain; Anna Malovannaya; Tapan M. Kadia; Naval Daver; Koji Sasaki; Koichi Takahashi; Danielle Hammond; Jayastu Senapati; Sanam Loghavi; Lauren B. Flores; Xiaoping Su; Courtney D. DiNardo

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML BRG1/BRM抑制剂与BET抑制剂或地西他滨的高效联合治疗高风险MECOM重排的急性髓系白血病

HemaSphere

IF14.6

2026-01-15

OAAI

Warren Fiskus; Christopher P. Mill; Jessica Piel; Mike Collins; Murphy Hentemann; Branko Cuglievan; Christine E. Birdwell; Kaberi Das; John A. Davis; Hanxi Hou; Antrix Jain; Anna Malovannaya; Lauren B. Flores; Tapan M. Kadia; Naval Daver; Koji Sasaki; Koichi Takahashi; Danielle Hammond; Jian Wang; Sanam Loghavi; Xiaoping Su; Courtney D. DiNardo; Ruud Delwel; Kapil N. Bhalla

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML BET抑制剂为基础的组合，靶向MECOM重排(r) AML中的新型依赖性

Leukemia

IF13.4

2025-12-19

OAAI

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms (MPN) in blastic phase 基于tasquinimod的联合方案在急变期骨髓增殖性肿瘤（MPN）中的临床前疗效

Blood Advances

IF7.1

2025-08-21

OAAI

Warren Fiskus; Lucia Masarova; Christopher P. Mill; Christine E. Birdwell; Kaberi Das; Hanxi Hou; John A. Davis; Antrix Jain; Anna Malovannaya; Taghi Manshouri; Andrew Dunbar; Surbhi Sharma; Tapan M. Kadia; Courtney D. DiNardo; Prithviraj Bose; Naveen Pemmaraju; Sanam Loghavi; Xiaoping Su; Raajit K. Rampal; Marie Törngren; Kapil N. Bhalla

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 (vol 13, 53, 2023)靶向表观遗传共依赖性增强了在MLL1-r或突变NPM1的AML中Menin抑制剂的抗AML疗效（卷13，53，2023）

BLOOD CANCER JOURNAL

IF11.6

2025-05-21

OAAI

Fiskus, Warren; Mill, Christopher P.; Birdwell, Christine; Davis, John A.; Das, Kaberi; Boettcher, Steffen; Kadia, Tapan M.; Dinardo, Courtney D.; Takahashi, Koichi; Loghavi, Sanam; Soth, Michael J.; Heffernan, Tim; Mcgeehan, Gerard M.; Ruan, Xinjia; Su, Xiaoping; Vakoc, Christopher R.; Daver, Naval; Bhalla, Kapil N.

Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community 儿童急性白血病中的Menin抑制剂: 全面回顾和建议，以加速与成人白血病和国际社会合作的进展

LEUKEMIA

IF13.4

2024-08-23

OAAI

Cuglievan, Branko; Kantarjian, Hagop; Rubnitz, Jeffrey E.; Cooper, Todd M.; Zwaan, C. Michel; Pollard, Jessica A.; DiNardo, Courtney D.; Kadia, Tapan M.; Guest, Erin; Short, Nicholas J.; Mccall, David; Daver, Naval; Nunez, Cesar; Haddad, Fadi G.; Garcia, Miriam; Bhalla, Kapil N.; Maiti, Abhishek; Catueno, Samanta; Fiskus, Warren; Carter, Bing Z.; Gibson, Amber; Roth, Michael; Khazal, Sajad; Tewari, Priti; Abbas, Hussein A.; Bourgeois, Wallace; Andreeff, Michael; Shukla, Neerav N.; Truong, Danh D.; Connors, Jeremy; Ludwig, Joseph A.; Stutterheim, Janine; Salzer, Elisabeth; Juul-Dam, Kristian L.; Sasaki, Koji; Mahadeo, Kris M.; Tasian, Sarah K.; Borthakur, Gautam; Dickson, Samantha; Jain, Nitin; Jabbour, Elias; Meshinchi, Soheil; Garcia-Manero, Guillermo; Ravandi, Farhad; Stein, Eytan M.; Kolb, E. Anders; Issa, Ghayas C.

Novel combination therapies to overcome non-genetic/adaptive menin inhibitor resistance in AML with MLL1r or mtNPM1

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Fiskus, Warren C.; Mill, Christopher P.; Piel, Jessica; Hentemann, Murphy; Birdwell, Christine E.; Das, Kaberi; Davis, John A.; Hou, Hanxi; Kadia, Tapan M.; Daver, Naval; Loghavi, Sanam; Cuglievan, Branko; Dinardo, Courtney D.; Bhalla, Kapil N.

Identifying novel therapies from unbiased screens in AML with MECOM re-arrangement

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Birdwell, Christine E.; Fiskus, Warren C.; Mill, Christopher P.; Kadia, Tapan M.; Daver, Naval; DiNardo, Courtney D.; Sasaki, Koji; Davis, John A.; Das, Kaberi; Hou, Hanxi; Cerebelli, Michele; Bhalla, Kapil N.

Novel agents with efficacy against germline mutant RUNX1 familial platelet disorder with myeloid malignancy (FPD-MM)

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Mill, Christopher P.; Fiskus, Warren C.; DiNardo, Courtney D.; Reville, Patrick K.; Davis, John A.; Birdwell, Christine E.; Das, Kaberi; Hou, Hanxi; Takahashi, Koichi; Loghavi, Sanam; Khoury, Joseph D.; Bhalla, Kapil

Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)

BLOOD CANCER JOURNAL

IF11.6

2024-02-05

OAAI

Mill, Christopher P.; Fiskus, Warren C.; DiNardo, Courtney D.; Reville, Patrick; Davis, John A.; Birdwell, Christine E.; Das, Kaberi; Hou, Hanxi; Takahashi, Koichi; Flores, Lauren; Ruan, Xinjia; Su, Xiaoping; Loghavi, Sanam; Khoury, Joseph D.; Bhalla, Kapil N.

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

LEUKEMIA

IF13.4

2023-12-12

PREAI

Birdwell, Christine E.; Fiskus, Warren; Kadia, Tapan M.; Mill, Christopher P.; Sasaki, Koji; Daver, Naval; Dinardo, Courtney D.; Pemmaraju, Naveen; Borthakur, Gautam; Davis, John A.; Das, Kaberi; Sharma, Sunil; Horrigan, Stephen; Ruan, Xinjia; Su, Xiaoping; Khoury, Joseph D.; Kantarjian, Hagop; Bhalla, Kapil N.

Pharmacodynamics and antitumor mechanism of the BRG1/BRM (SMARCA4/2) inhibitor FHD-286 in a Phase 1 study in subjects with AML or MDS

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Collins, Mike; Thomsen, Astrid; Elliott, GiNell; Wan, Jessica; Horrigan, Kim; Delestre, Laure; Penard-Lacronique, Virginie; De Botton, Stephane; Fiskus, Warren; Bhalla, Kapil N.; DiNardo, Courtney; Agresta, Samuel; Piel, Jessica; Hentemann, Martin

Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2023-09-04

PREAI

Bataller, Alex; Loghavi, Sanam; Gerstein, Yoheved; Bazinet, Alexandre; Sasaki, Koji; Chien, Kelly S.; Hammond, Danielle; Montalban-Bravo, Guillermo; Borthakur, Gautam; Short, Nicholas; Issa, Ghayas C.; Kadia, Tapan M.; Daver, Naval; Tang, Guilin; Quesada, Andres; Patel, Keyur P.; Ravandi, Farhad; Fiskus, Warren; Mill, Cristopher P.; Kantarjian, Hagop M.; Bhalla, Kapil; Garcia-Manero, Guillermo; Oran, Betul; Dinardo, Courtney D.

Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies

CLINICAL CANCER RESEARCH

IF10.2

2023-08-16

PREAI

Senapati, Jayastu; Fiskus, Warren C.; Daver, Naval; Wilson, Nathaniel R.; Ravandi, Farhad; Garcia-Manero, Guillermo; Kadia, Tapan; Dinardo, Courtney D.; Jabbour, Elias; Burger, Jan; Short, Nicholas J.; Alvarado, Yesid; Jain, Nitin; Masarova, Lucia; Issa, Ghayas C.; Qiao, Wei; Khoury, Joseph D.; Pierce, Sherry; Miller, Darla; Sasaki, Koji; Konopleva, Marina; Bhalla, Kapil N.; Borthakur, Gautam; Pemmaraju, Naveen

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

BLOOD CANCER JOURNAL

IF11.6

2023-04-13

OAAI

Fiskus, Warren; Mill, Christopher P.; Birdwell, Christine; Davis, John A.; Das, Kaberi; Boettcher, Steffen; Kadia, Tapan M.; DiNardo, Courtney D.; Takahashi, Koichi; Loghavi, Sanam; Soth, Michael J.; Heffernan, Tim; McGeehan, Gerard M.; Ruan, Xinjia; Su, Xiaoping; Vakoc, Christopher R.; Daver, Naval; Bhalla, Kapil N.

The dual BRM/BRG1 (SMARCA2/4) inhibitor FHD-286 induces differentiation in preclinical models of AML

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Collins, Mike; Thomsen, Astrid; Gartin, Ashley; Sandoval, Gabriel J.; Adam, Ammar; Reilly, Sarah; Delestre, Laure; Penard-Lacronique, Virginie; Fiskus, Warren; Bhalla, Kapil; De Botton, Stephane; Agresta, Sam; Piel, Jessica; Hentemann, Murphy

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Birdwell, Christine E.; Fiskus, Warren C.; Kadia, Tapan M.; Mill, Christopher P.; Davis, John A.; Das, Kaberi; Horrigan, Stephen; Bhalla, Kapil N.

Pre-clinical efficacy of targeting BAF complexes through inhibition of the dual ATPases BRG1 and BRM by FHD-286 in cellular models of AML

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Fiskus, Warren C.; Piel, Jessica; Hentemann, Murphy; Mill, Christopher P.; Birdwell, Christine E.; Das, Kaberi; Davis, John A.; Kadia, Tapan M.; Daver, Naval; Loghavi, Sanam; DiNardo, Courtney D.; Bhalla, Kapil N.

研究方向